Avalon GloboCare Corp. (NASDAQ:ALBT) Short Interest Update

Avalon GloboCare Corp. (NASDAQ:ALBT) was the target of a significant decrease in short interest in the month of November. As of November 15th, there was short interest totalling 78,800 shares, a decrease of 27.1% from the October 31st total of 108,100 shares. Based on an average daily volume of 648,600 shares, the days-to-cover ratio is presently 0.1 days. Currently, 19.4% of the company’s stock are sold short.

Avalon GloboCare Price Performance

Avalon GloboCare stock opened at $2.80 on Friday. The firm’s fifty day moving average price is $3.09 and its 200 day moving average price is $4.81. The company has a market capitalization of $3.05 million, a price-to-earnings ratio of -0.14 and a beta of 0.31. Avalon GloboCare has a 12-month low of $2.11 and a 12-month high of $21.60.

Avalon GloboCare Company Profile

Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States and China. The company develops and delivers transformative cellular therapeutics, precision diagnostics, and clinical laboratory services. Its leading candidates are AVA-001, an anti-CD19 CAR-T, which has completed first-in-human clinical trial for relapsed/refractory (R/R) B-cell lymphoblastic leukemia; and AVA-011 that has completed pre-clinical laboratory studies and undergoing IND-enabling process development stage to generate cGMP-grade AVA-011 CAR-T cells.